started down the path of collating historical Related Party Transaction amounts and found these gems
2018 Annual Report - just when everyone was celebrating the $100m sales growth that was going to come from expansion into China via signing with Careline
Interesting:
soft Revenue and EBITDA targets only, no setting the bar of achieving NPAT !!
chaaa chiiiing
2016 Annual Report - selling private companies to FOD shareholders
Gross Profit, EBITDA, $2m Marketing Spend !!! - where's the focus upon producing Net Profit for Shareholders ?
And then remember later in 2016 (FY2017 year) the Board voted down the acquisition of another Matt Bailey private company as being overpriced and at a bad time for the FOD share price and the extra dilution effect it would create
I'm starting to see a bit of a pattern here .......
Can we get the 2016 Board back do you reckon ?
FOD Price at posting:
2.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)